Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The transgenic mouse line PS2APP (PS2N141I x APP(swe)) develops an age-related cognitive decline associated with severe amyloidosis, mimicking the pathophysiologic processes in Alzheimer disease (AD). In the quest for biomarkers to monitor, noninvasively, the progression of the disease, we used magnetic resonance imaging and 1H-spectroscopy to characterize PS2APP mice throughout their life span. Morphometric measurements revealed only small size differences to controls. The metabolic profile, however, showed clear indicators of hypometabolism with age in the PS2APP mice: both N-acetyl-aspartate and glutamate were significantly reduced in the older animals. These spectroscopic measures in vivo correlated well with the plaque load in the frontal cortex. A diagnostic test, based on these measures, reached 92% sensitivity and 82% specificity at age 20 months. These noninvasive biomarkers can be exploited in preclinical pharmaceutical research to cope with the high variability in transgenic animal models and to enhance the power of drug efficacy studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene selection for cancer classification using support vector machines
Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002) · Machine Learning · doi:10.1023/a:1012487302797 · Cited by 9,954
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“Most mouse models described in the literature overexpress mutated forms of human amyloid precursor protein (APP) (Chishti et al., 2001; Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997); accelerated h-amyloid (Ah) deposition was achieved in mice coexpressing human presenilin 1…”
BackgroundFrequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656 · cited 1×
“…resonance spectroscopy; N-acetyl-aspartate; Glutamate Introduction A definitive diagnosis of Alzheimer disease (AD) today is only possible postmortem, detecting the two hallmarks of the disease— amyloid plaques and neurofibrillar tangles—in brain tissue of the patient (Braak and Braak, 1997).”
BackgroundTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386
Chishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 8×
“Most mouse models described in the literature overexpress mutated forms of human amyloid precursor protein (APP) (Chishti et al., 2001; Games et al., 1995; Hsiao et al., 1996; Sturchler-Pierrat et al., 1997); accelerated h-amyloid (Ah) deposition was achieved in mice coexpressing human presenilin 1…”
BackgroundInfluentialQuantitative NMR measurements of hippocampal atrophy in Alzheimer's disease
Seab, J. P., Jagust, W. J., Wong, S. T. S., Roos, M. S., Reed, B. R., & Budinger, T. F. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910080210 · Cited by 364 · cited 1×
“Several studies could demonstrate an increased rate of atrophy either of the whole brain (e.g., Fox et al., 1996) or of structures such as the entorhinal cortex (e.g., Jack et al., 1992; Seab et al., 1988).”
Background
Cited by
(1997) · Obesity Surgery · doi:10.1381/096089297765555359 · Cited by 3,916
Nuriel, T., Angulo, S. L., Khan, U., Ashok, A., Chen, Q., Figueroa, H. Y., Emrani, S., Liu, L., Herman, M., Barrett, G., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01444-0 · Cited by 181
In Vivo mouse imaging and spectroscopy in drug discovery
Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118
A review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93
Weidensteiner, C., Metzger, F., Bohrmann, A. B. B., Kuennecke, B., & von Kienlin, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21985 · Cited by 56
“Global brain atrophy was not detected in the similar PS2APP mouse line (10).”
BackgroundSelf-citation
Metadata
- Authors
- von Kienlin, M., Künnecke, B., Metzger, F., Steiner, G., Richards, J. G., Ozmen, L., Jacobsen, H., & Loetscher, H.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 18
- Issue
- 1
- Pages
- 32-39
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2028524574
- Cited by
- 104
- References
- 7
- FWCI
- 3.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. https://app.cochat.ai/papers/10.1016/j.nbd.2004.09.005
- The paper
- von Kienlin, M., Künnecke, B., Metzger, F., Steiner, G., Richards, J. G., Ozmen, L., Jacobsen, H., & Loetscher, H. (2005). Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2004.09.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.